课题基金 / 基金详情

LONG TERM SAFETY AND TOLERABILITY TO MK-0467 IN CHRONIC ASTHMA

LONG TERM SAFETY AND TOLERABILITY TO MK-0467 IN CHRONIC ASTHMA
MK-0467 在慢性哮喘中的长期安全性和耐受性
批准号：
6246878
负责人：
JOAN REIBMAN
金额：
$2.39万
依托单位：
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
依托单位国家：
美国
项目类别：
财政年份：
1997
资助国家：
美国
项目状态：
已结题
起止时间：
1997-02-12 至 1997-11-30
来源：
https://reporter.nih.gov/project-details/6246878
关键词：
asthma clinical research clinical trials drug screening /evaluation human subject human therapy evaluation inhibitor /antagonist leukotrienes respiratory disorder chemotherapy

项目摘要

项目成果

JOAN REIBMAN的其他基金

相似基金

相关文献

中文摘要
翻译
这个开放的，控制的扩展协议640 (MK-0476 vs
英文摘要
The purpose of this open, controlled extension of Protocol 640 (MK-0476 vs placebo) is to collect additional longterm safety and tolerablity data when MK-0467, a potent leukotriene antagonist is administered at a daily dose of 10 mg at bedtime.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Cognitive decline among WTC survivors with chronic mental and physical disorders
Cognitive decline among WTC survivors with chronic mental and physical disorders
Uncontrolled Lower Respiratory Symptoms in the WTC Survivor Program
DISEASE MODIFYING GENES IN SEVERE ASTHMA
海外基金